The organization sat down with Colleen Lindholz, president of Kroger Health, to discuss the company's involvement in NACDS RxIMPACT grassroots programs.
Xifaxin 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea in adults.
The Biosimilars Council released a new analysis by IQVIA that reveals a PBM strategy to protect $2 billion in profits by “strangling” the biosimilar market and preventing savings for patients.